Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Renault Group to sell to Nissan up to 100,242,900 Nissan shares representing approximately 2.5% of Nissan capital
-
Form 8.5 (EPT/RI) - Abrdn European Logistics Income Plc
-
Form 8.5 (EPT/RI) - musicMagpie Plc
-
Form 8.5 (EPT/RI) - Mattioli Woods Plc
-
The Swedish and English version of HMS Network’s Annual Report 2023 is now available
-
Form 8.5 (EPT/RI) - Accrol Group Holdings Plc
-
Zscaler Finds Enterprise Use of AI/ML Tools Skyrocketed Nearly 600% Over the Last Year, Putting Enterprises at Risk
-
Nasdaq Study Shows Structural Reform Needed to Unlock Global Carbon Markets
-
Norsk Hydro: Invitation to Hydro's first quarter results 2024
-
Caledonia Mining Corporation Plc: Notice of Availability of AGM Materials
-
AB Akola Group to build a seed factory for EUR 9.5 million
-
Aspocomp has published its Annual Report 2023 and Corporate Governance Statement 2023
-
Endeavour Reports Strong FY-2023 Results
-
Endeavour Announces Completion of Investigation and Key Findings
-
Irish Residential Properties Sub-Fund 1: Form 8.3 - Irish Residential Properties REIT PLC
-
-
Convening of the ordinary general meeting of shareholders of April 26, 2024
-
QPR Software Plc: Managements’ Transactions (Salo)
-
QPR Software Plc: Managements’ Transactions (Maliniemi)
-
QPR Software Plc: Managements’ Transactions (Aspinen)
-
QPR Software Plc: Managements’ Transactions (Erkheikki)
-
QPR Software Plc: Managements’ Transactions (Kerkelä-Hiltunen)
-
QPR Software Plc: Managements’ Transactions (Lehto)
-
Norsk Hydro: Invitation to Hydro's first quarter results 2024
-
Michelin : Disclosure of trading in own shares - March 27st 2024
-
Subsea 7 S.A. Notice of Annual General Meeting
-
Sosei Heptares Confirms Re-election of its Board and Executive Management Team and the Approval of Change of Company Name to Nxera Pharma
-
Vidac Pharma receives Japanese Patent Office Notice of Allowance for VDA-1275 cancer drug candidate
-
BGHL (GBP): NAV(s)
-
BGHL (EUR): NAV(s)
-
argenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease
-
CEO Magazine Ranks Georgia State’s EMBA in Top 10 U.S.-Based Programs, Top 30 Worldwide
-
Start of Day Message
-
argenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease
-
Ad hoc announcement: GAM announces 2023 full year results, proposal to strengthen the balance sheet and strategic progress
-
IMCD Benelux expands its Beauty & Personal Care presence with the acquisition of Gova Ingredients
-
Santhera Announces NDA for Vamorolone in Duchenne Muscular Dystrophy Accepted and Granted Priority Review by China’s NMPA
-
Harju Elekter Group's audited Annual Report 2023
-
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Burgundy Diamond Mines announces 2023 year-end results
-
Burgundy Diamond Mines announces 2023 year-end results
-
Burgundy Diamond Mines announces 2023 year-end results
-
Burgundy Diamond Mines announces 2023 year-end results
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Danske Bank A/S, transactions by persons discharging managerial responsibilities
-
Burgundy Diamond Mines announces 2023 year-end results
-
Burgundy Diamond Mines announces 2023 year-end results
-
Burgundy Diamond Mines announces 2023 year-end results
-
WatchGuard Threat Lab Analysis Shows Surge in Evasive Malware Supercharging an Already Powerful Threat Wave
